Document is current

Any future updates will be listed below

Tumorschmerztherapie: Hydromorphon — Präferenzsubstanz dank guter Verträglichkeit

Crossref DOI link: https://doi.org/10.1007/s00940-017-0575-7

Published Online: 2017-05-08

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark